| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-07 10:56:50 UTC |
|---|
| Updated at | 2022-09-07 10:56:50 UTC |
|---|
| NP-MRD ID | NP0248627 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (1r,3s,5s,8r,10s,12r,13s)-5,10,17,17-tetramethyl-14-methylidene-15-oxo-4,9-dioxatetracyclo[11.3.1.0³,⁵.0⁸,¹⁰]heptadecan-12-yl acetate |
|---|
| Description | Hypoestoxide belongs to the class of organic compounds known as carboxylic acid esters. These are carboxylic acid derivatives in which the carbon atom from the carbonyl group is attached to an alkyl or an aryl moiety through an oxygen atom (forming an ester group). (1r,3s,5s,8r,10s,12r,13s)-5,10,17,17-tetramethyl-14-methylidene-15-oxo-4,9-dioxatetracyclo[11.3.1.0³,⁵.0⁸,¹⁰]heptadecan-12-yl acetate was first documented in 2003 (PMID: 12962514). Based on a literature review a significant number of articles have been published on hypoestoxide (PMID: 26683203) (PMID: 24315792) (PMID: 18979485) (PMID: 17729410) (PMID: 17568581). |
|---|
| Structure | CC(=O)O[C@@H]1C[C@]2(C)O[C@@H]2CC[C@]2(C)O[C@H]2C[C@@H]2CC(=O)C(=C)[C@@H]1C2(C)C InChI=1S/C22H32O5/c1-12-15(24)9-14-10-18-21(5,27-18)8-7-17-22(6,26-17)11-16(25-13(2)23)19(12)20(14,3)4/h14,16-19H,1,7-11H2,2-6H3/t14-,16+,17+,18-,19-,21-,22-/m0/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C22H32O5 |
|---|
| Average Mass | 376.4930 Da |
|---|
| Monoisotopic Mass | 376.22497 Da |
|---|
| IUPAC Name | (1R,3S,5S,8R,10S,12R,13S)-5,10,17,17-tetramethyl-14-methylidene-15-oxo-4,9-dioxatetracyclo[11.3.1.0^{3,5}.0^{8,10}]heptadecan-12-yl acetate |
|---|
| Traditional Name | (1R,3S,5S,8R,10S,12R,13S)-5,10,17,17-tetramethyl-14-methylidene-15-oxo-4,9-dioxatetracyclo[11.3.1.0^{3,5}.0^{8,10}]heptadecan-12-yl acetate |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC(=O)O[C@@H]1C[C@]2(C)O[C@@H]2CC[C@]2(C)O[C@H]2C[C@@H]2CC(=O)C(=C)[C@@H]1C2(C)C |
|---|
| InChI Identifier | InChI=1S/C22H32O5/c1-12-15(24)9-14-10-18-21(5,27-18)8-7-17-22(6,26-17)11-16(25-13(2)23)19(12)20(14,3)4/h14,16-19H,1,7-11H2,2-6H3/t14-,16+,17+,18-,19-,21-,22-/m0/s1 |
|---|
| InChI Key | HNPAHGHFONBTLV-PKAJHXTNSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as carboxylic acid esters. These are carboxylic acid derivatives in which the carbon atom from the carbonyl group is attached to an alkyl or an aryl moiety through an oxygen atom (forming an ester group). |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Carboxylic acid derivatives |
|---|
| Direct Parent | Carboxylic acid esters |
|---|
| Alternative Parents | |
|---|
| Substituents | - Cyclic ketone
- Ketone
- Carboxylic acid ester
- Oxacycle
- Organoheterocyclic compound
- Monocarboxylic acid or derivatives
- Ether
- Oxirane
- Dialkyl ether
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Kim C, Ojo-Amaize E, Spencer B, Rockenstein E, Mante M, Desplats P, Wrasidlo W, Adame A, Nchekwube E, Oyemade O, Okogun J, Chan M, Cottam H, Masliah E: Hypoestoxide reduces neuroinflammation and alpha-synuclein accumulation in a mouse model of Parkinson's disease. J Neuroinflammation. 2015 Dec 18;12:236. doi: 10.1186/s12974-015-0455-9. [PubMed:26683203 ]
- Stone AV, Loeser RF, Vanderman KS, Long DL, Clark SC, Ferguson CM: Pro-inflammatory stimulation of meniscus cells increases production of matrix metalloproteinases and additional catabolic factors involved in osteoarthritis pathogenesis. Osteoarthritis Cartilage. 2014 Feb;22(2):264-74. doi: 10.1016/j.joca.2013.11.002. Epub 2013 Dec 4. [PubMed:24315792 ]
- McGrath NA, Lee CA, Araki H, Brichacek M, Njardarson JT: An efficient substrate-controlled approach towards hypoestoxide, a member of a family of diterpenoid natural products with an inside-out [9.3.1]bicyclic core. Angew Chem Int Ed Engl. 2008;47(49):9450-3. doi: 10.1002/anie.200804237. [PubMed:18979485 ]
- Ojo-Amaize EA, Cottam HB, Oyemade OA, Okogun JI, Nchekwube EJ: Hypoestoxide inhibits tumor growth in the mouse CT26 colon tumor model. World J Gastroenterol. 2007 Sep 14;13(34):4586-8. doi: 10.3748/wjg.v13.i34.4586. [PubMed:17729410 ]
- Ojo-Amaize EA, Nchekwube EJ, Cottam HB, Oyemade OA, Adesomoju AA, Okogun JI: Plasmodium berghei: antiparasitic effects of orally administered hypoestoxide in mice. Exp Parasitol. 2007 Oct;117(2):218-21. doi: 10.1016/j.exppara.2007.04.012. Epub 2007 May 10. [PubMed:17568581 ]
- Donnelly LE, Rogers DF: Therapy for chronic obstructive pulmonary disease in the 21st century. Drugs. 2003;63(19):1973-98. doi: 10.2165/00003495-200363190-00002. [PubMed:12962514 ]
- LOTUS database [Link]
|
|---|